Real-World Clinical Outcomes of Ribociclib in Combination with a Non-Steroidal Aromatase Inhibitor and a Luteinizing Hormone-Releasing Hormone Agonist in Premenopausal HR+/HER2- Advanced Breast Cancer Patients: An Italian Managed Access Program
瑞博西尼联合非甾体类芳香化酶抑制剂和促黄体生成素释放激素激动剂治疗绝经前HR+/HER2-晚期乳腺癌患者的真实世界临床结果：一项意大利管理式准入计划
期刊:Current Oncology
影响因子:3.4
doi:10.3390/curroncol29090521
Staropoli, Nicoletta; Geuna, Elena; Rinaldi, Gaetana; Bisagni, Giancarlo; Scotti, Vieri; Faggioni, Giovanni; Vannini, Laura; Arcara, Carlo; Moretti, Gabriella; Gunnellini, Marco; Coltelli, Luigi; Verderame, Francesco; Livi, Lorenzo; Sanna, Giuseppina; Grasso, Donatella; Abbinante, Giulia; Ragni, Francesca
